Improving Blood Pressure Control Through the myBPmyLife mHealth Application
myBPmyLife
1 other identifier
interventional
608
1 country
2
Brief Summary
This study is enrolling eligible participants that have high blood pressure. Reducing dietary salt intake and engaging in regular physical activity is known to decrease blood pressure in people with hypertension. This trial will determine whether a smartwatch and a mobile health application, which together deliver notifications, can increase activity levels and reduce salt intake for people with high blood pressure. All study activities will be completed online or via a mobile medical application. Participants will not have any face-to-face visits with the study team.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Dec 2021
Typical duration for not_applicable hypertension
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2021
CompletedFirst Posted
Study publicly available on registry
December 13, 2021
CompletedStudy Start
First participant enrolled
December 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 27, 2024
CompletedFebruary 20, 2024
February 1, 2024
2.1 years
November 30, 2021
February 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in systolic blood pressure between baseline and 6-months
Baseline, 6 months
Secondary Outcomes (8)
Number of self-reported low-sodium food choices within 24 hours of a diet notification
within 24 hours of a diet notification
Number of steps taken within 60 minutes of a physical activity notification
within 60 minutes of a physical activity notification
Change in mean daily sodium intake between baseline and 6-months (Block Sodium Screener)
Baseline, up to 6 months
Change in mean daily step count between baseline and 6-months (i.e., 180 days)
Baseline, up to 6 months
Change in diastolic blood pressure from baseline to 6-months (i.e., 180 days)
Baseline, up to 6 months
- +3 more secondary outcomes
Study Arms (2)
Control arm
OTHERParticipants in the control group will be provided a smartwatch and home blood pressure monitor. They will also be provided with general instructions on how to download and install a physical activity and diet regulation applications (apps) available to the general public. They will still be asked to perform the blood pressure monitoring at regularly scheduled time periods, but do not receive the intervention components notifications in myBPmyLife app developed for the experimental group.
Dietary plus physical activity JITAI
EXPERIMENTALParticipants in the experimental group will be provided a smarthwatch and home blood pressure monitor. They will then receive the myBPmyLife app that includes push notifications to promote increased physical activity and improve low sodium food choices. The app also provides goal setting for weekly step count and information on low-sodium food choices, as well as feedback on achieving the goals using a dashboard with visualization tools within the mobile application.
Interventions
A Fitbit smartwatch and home blood pressure monitor will be mailed to participants (in both the experimental and control arms). Participants in the intervention arm then will set up and utilize the myBPmyLife app. This app includes push notifications to promote increased physical activity and improve low-sodium food choices, establish goal setting for weekly step count and low sodium food choices, and deliver feedback on achieving the goals using a dashboard visualization within the mobile application.
Participants will receive the myBPmyLife app, a smartwatch, and blood pressure cuff. The myBPmyLife app will not be fully activated (as they are in the control arm). They will be provided with the option of downloading and installing a mHealth app that is publicly available. In this arm they will also perform the blood pressure monitoring, but do not receive the intervention components through the myBPmyLife app.
Eligibility Criteria
You may qualify if:
- Self-reported history of hypertension and no hypertensive medication changes in the last 4 weeks.
- A smartphone with a compatible Apple or Android operating system installed and able to download and use the myBPmyLife app including accepting all permissions
- A valid email address
- Fluent in spoken and written English
- Signed written informed consent. (Note that each participant must be able to consent for themselves.)
You may not qualify if:
- Contraindication to performing physical activity or following a sodium restriction diet. The participant must be able to walk and eat on their own without assistive devices.
- Unstable symptoms or markedly elevated BP at enrollment (defined as systolic BP\>180 mmHg, diastolic BP\>120 millimeters of mercury (mmHg))
- Known secondary causes of hypertension (e.g., adrenal insufficiency, pheochromocytoma), heart failure, or end-stage renal disease
- Difficulty using an upper arm blood pressure cuff due to biceps size or end-stage renal disease or difficulty comfortably wearing a smartwatch
- Wrist too large to wear a smartwatch comfortably.
- Daily sodium intake less than 1500 mg/day as measured by the sodium screener
- Currently pregnant or planning to become pregnant in the next six months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- American Heart Associationcollaborator
Study Sites (2)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Hamilton Community Health Network
Flint, Michigan, 48505, United States
Related Publications (2)
Dorsch MP, Golbus JR, Stevens R, Trumpower B, Basu T, Luff E, Warden K, Giacalone M, Bailey S, Rubick GV, Mishra S, Klasnja P, Newman MW, Skolarus LE, Nallamothu BK. Physical activity and diet just-in-time adaptive intervention to reduce blood pressure: a randomized controlled trial. NPJ Digit Med. 2025 Jul 14;8(1):438. doi: 10.1038/s41746-025-01844-3.
PMID: 40659778DERIVEDGolbus JR, Jeganathan VSE, Stevens R, Ekechukwu W, Farhan Z, Contreras R, Rao N, Trumpower B, Basu T, Luff E, Skolarus LE, Newman MW, Nallamothu BK, Dorsch MP. A Physical Activity and Diet Just-in-Time Adaptive Intervention to Reduce Blood Pressure: The myBPmyLife Study Rationale and Design. J Am Heart Assoc. 2024 Jan 16;13(2):e031234. doi: 10.1161/JAHA.123.031234. Epub 2024 Jan 16.
PMID: 38226507DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brahmajee K Nallamothu, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Internal Medicine
Study Record Dates
First Submitted
November 30, 2021
First Posted
December 13, 2021
Study Start
December 21, 2021
Primary Completion
January 27, 2024
Study Completion
January 27, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share